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Performance of the DNA-Citoliq liquid-based cytology system compared with conventional
smears
Objective: To evaluate the performance of a new, manual, simplified liquid-based system, DNA-Citoliq (Digene
Brasil), employed under routine conditions as compared to conventional smears collected from six collaborating
private laboratories.
Methods: A panel of cytopathologists, who served as the gold standard diagnosis, adjudicated discordant
opinions.
Results: Of 3206 pairs of slides considered valid for comparison, there were 3008 in full agreement (93.8%),
112 (3.5%) with one diagnostic category discrepancies, and 86 (2.7%) discordant cases. Among the 288 borderline+
by either method, DNA-Citoliq detected abnormalities in 243 (84.4%), and conventional smears (CS)
detected abnormalities in 178 (61.8%) (McNemar test, P < 0.000), a 36.5% increased detection of
borderline+ cases.
Conclusions: For mild dyskaryosis, DNA-Citoliq detected 176 cases and CS 125 cases (McNemar test,
P < 0.000); and for moderate+severe dyskaryosis 66 versus 32 cases respectively (McNemar test, P < 0.000).
Keywords: liquid-based cytology, DNA-Citoliq system, thin layer cytology, split-sample study, severe
dyskaryosis, HPV
Introduction
Liquid-based cytology (LBC) has become an important
tool in uterine cervix cytopathology.1–3 Many split-
samples and direct-to-vial studies have shown higher
detection rates of both low-grade and high-grade
intra-epithelial lesions than conventional smears with
either of the two FDA-cleared systems, ThinPrep
(Cytyc Corp., Boxborough, MA, USA) and SurePath
(TriPath Imaging, Inc., Elon College, NC, USA).4,5
Besides identifying minor morphological peculiarities,
readily identifiable after a short training course, a
major problem for wider adoption of LBC has been the
increased costs of LBC.2
Mielzynska-Lohnas et al.6 reported on the develop-
ment of a Universal Collection Medium (UCM), a
useful solution for preservation of both nucleic acids
and morphology. A new, simplified manual system for
simultaneous preparation of up to 12 slides fixed in
UCM has been developed by Digene Brasil (Sao Paulo,
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Brasil). The system, known as the DNA-Citoliq system
(DNA-Citoliq), yields thin layer preparations, with
preservation of the morphological characteristics of
the uterine cervix epithelial cells, either normal or
neoplastic.7
The objective of the present study was to assess the
performance of DNA-Citoliq in the detection of
cervico-vaginal epithelial lesions under routine
conditions in six Brazilian private cytopathology
laboratories.
Methods
A convenience study of 3271 samples, collected from
women who attended clinics at the six collaborating
laboratories for a routine cervical smear, either for
their annual screening or during a gynaecological
examination, was performed from September 2001 to
April 2002.
Women with at least one of the following criteria
were excluded: previous uterine cervix surgery, preg-
nancy and refusal to participate.
Conventional smear and DNA-Citoliq procedures
Participating laboratories received a 1-day workshop to
train technicians and cytopathologists on technical
procedures, and compliance with the Technical Man-
ual. In total, 3271 pairs of samples were collected and
prepared in six different private Brazilian laboratories:
CIAP (Brasilia), Instituto de Patologia (Porto Alegre),
Instituto Roberto Alvarenga (Belo Horizonte), Annalab
(Curitiba), Biocito (Goiania), and Saloma˜o & Zoppi
(Sa˜o Paulo). Material for the conventional Pap test was
always collected first with the aid of an Ayre’s wooden
spatula scraping the ectocervix and a conical Digene
brush for the endocervix. The material collected was
immediately smeared on a slide and alcohol-fixed.
Afterwards, the same conical brush with residual
endocervical sample was used for brushing the ecto-
cervix. The brush was then inserted into a plastic tube
with 1.0 ml of UCM, the brush shaft was broken at the
marked area, and the tube was capped and gently
shaken for 30 seconds.
The slide preparation followed the DNA-Citoliq
Protocol already reported.8 In short, the system
consists of an aluminium device, Prepgene (weight
3 kg with dimension of 37 · 10 · 4 cm), developed to
hold Duogene, which contains a slide holder (Lami-
gene) and a filter holder (Filtrogene). Lamigene is
made of polypropylene, holds 12 cytological slides,
and Filtrogene has a high-density polystyrene base, to
which a strip of absorbent material (with 12 polycar-
bonate membranes) is attached. These membranes are
25 mm in diameter with a 5-lm pore size. Slides from
samples collected in UCM are manually prepared
using Prepgene, a high-resistance aluminium alloy,
with tight fittings with Lamigene on the upper part
and Filtrogene on the lower part. By locking the
system laterally, the slides are fixed and compressed
against Filtrogene.
Briefly, the steps in slide preparation are:
• mix each tube thoroughly by vortexing individu-
ally at high speed for 15 seconds;
• immediately before pipetting, vortex again for
5 seconds;
• remove the tube cap, and pipette 200 lL of the
UCM specimen;
• dispense the specimen onto the polycarbonate
membrane, spreading the liquid uniformly on the
entire membrane area;
• close and lock the Prepgene lid, and wait for
10 seconds. During this step, the cells are
imprinted from the membrane to the glass slide;
• unlock and raise the Prepgene lid backwards
carefully;
• remove Lamigene and fix the slides with spray
fixative, or fully dip Lamigene in an appropriate
container with absolute alcohol;
• perform Papanicolaou stain;
• after use dispose of Lamigene and Filtrogene in a
biohazard waste container.
Criteria for slide review and definitions of the final diagnoses
All cases were primarily assessed according to the
Brazilian Health System/Brazilian Society of Cyto-
pathology Nomenclature (1994), based on WHO
classification of squamous lesions in three classes
(CIN1, 2 and 3),9 with the addition of criteria for
sample quality assessment from the Bethesda 2001
NCI Consensus.10 Presently, all diagnoses were
reported according to the United Kingdom British
Society for Clinical Cytology (BSCC) classifica-
tion.11,12
Conventional smears and DNA-Citoliq slides were
coded and studied separately by the cytopathologist
from each laboratory. Whenever both samples of the
pair were considered adequate and diagnosed as
negative, the slide was not referred to the reference
laboratory, except when included in the 5% random
sample used for quality control. Both conventional
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and DNA-Citoliq samples were assessed blinded by the
screeners.
In order to be deemed adequate, the slide should
have an estimated minimum of at least 8000/12 000
cells for the conventional smear and 5000 for LBC, as
proposed by the Bethesda system.10 Preparations with
more than 75% of squamous cells obscured by factors
such as inflammatory cells and red blood cells were
considered unsatisfactory.
All cases fulfilling at least one of the following
criteria had both slides of the pair submitted to a
review at the central laboratory:
1 Unsatisfactory sample: whenever one slide of the
pair was considered unsatisfactory, both slides
were submitted to review.
2 Presence of significant abnormalities: borderline,
mild, moderate or severe dyskaryosis and inva-
sion.
3 Presence of glandular atypia, in situ (AIS) or
invasive adenocarcinoma (Adenoca).
4 Diagnostic category discrepancies in each sample
of the pair.
5 Five per cent of cases diagnosed as negative,
randomly selected for review.
6 Cases in which the cytopathologist of the original
laboratory asked for a second opinion.
In cases where both the primary and the reference
laboratories reached the same diagnosis this was
considered the definitive diagnosis. Whenever dis-
cordant, a definitive diagnosis was obtained by con-
sensus from a panel of all cytopathologists involved in
the project by examining the cases with a multi-head
microscope.
Statistical analysis
The significance of differences in the rates of detection
of abnormalities between the two systems of sample
preparation was examined by the McNemar test
(two-category data) at a significance level of
P < 0.05. Confidence intervals were calculated.
Results
Sample adequacy
The 3271 specimens are the basis for our analysis.
Samples prepared according to the DNA-Citoliq pro-
cedure were, in the vast majority of cases, well
distributed in the 25 mm diameter circle, with exten-
sive thin-layered areas, although groups of crowded
cells were also seen. Conventional smears were
satisfactory in 99.7% of the samples and unsatisfac-
tory in 0.3% [95% confidence interval (CI): 0.1–
0.6%]. Residual samples processed by DNA-Citoliq
were satisfactory in 98.2% and unsatisfactory in 1.8%
(95% CI 1.4–2.4%). The most relevant factors for
inadequacy of a sample were hypocellularity, reported
in 20 slides, cellular overlapping obscuring more than
75% of the slide in 13 cases, clumped red blood cells
in 11 and clusters of leucocytes in nine slides.
Squamous cell lesions
Cellular features were well defined in DNA-Citoliq
samples. Cell membranes and cellular contours were
evident and smooth, and cytoplasmic volume and
staining properties followed classical patterns of cyto-
logy. Clarity of nuclear shape and chromatin distri-
bution were conducive to a detailed evaluation of
cytodiagnostic criteria for each pattern of epithelial
lesion. Diagnostic cells were numerous in many
abnormal cases. Koilocytes were remarkable, with
clear-cut perinuclear halos and nuclear atypia. Nuc-
lear cytoplasmic ratio and chromatin texture of
squamous intraepithelial lesions (SIL) lesions were
evident, as depicted in Figure 1. Severley dyskaryotic
cells were, in several cases, smaller than usual, with
basophilic cytoplasm and central nuclei showing
irregular contours and coarse chromatin. Occasionally
cells with severe dyskaryosis were seen in crowded
Figure 1. Cellular features of major lesions in DNA-Citoliq
samples: koilocytes present as large cells with sharp cell
membranes, clear cytoplasm and enlarged nuclei with mild
chromatin atypia.
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clusters, resembling coarse groups of undifferentiated
cells, with a small rim of cytoplasm (Figures 2 and 3).
In the four cases diagnosed as invasive squamous
cell carcinoma with DNA-Citoliq, eosinophilic kerati-
nized cytoplasm, large nuclei with irregular contours
and chromatin clumps were observed. Cell size and
shape were variable, and several spindle cells were
seen. DNA-Citoliq samples, in contrast to conven-
tional smears, showed several fields with neoplastic
cells on a clean background. Occasionally, tumour
diathesis consisting of cellular debris, leucocytes and
red blood cells were found in clumps (Figure 4).
Table 1 illustrates the comparison among the diag-
noses of squamous cell lesions achieved by DNA-
Citoliq and conventional smears. Of 3206 adequate
pairs of slides there was full agreement in 93.8%
Figure 2. Cellular features of major lesions in DNA-Citoliq
samples: moderate dyskaryosis cells may look smaller than
those seen at conventional smear. Moderate increase in
nuclear to cytoplasm ratio and chromatin distribution are
characteristic.




Negative Borderline Mild dyskaryosis Moderate dyskaryosis Severe dyskaryosis Invasion Total
Negative 2918 44 38 16 12 0 3028
Borderline 31 12 7 1 2 0 53
Mild dyskaryosis 14 8 56 12 0 0 90
Moderate dyskaryosis 0 2 5 6 4 0 17
Severe dyskaryosis 0 1 0 0 13 1 15
Invasion 0 0 0 0 0 3 3
Total 2963 67 106 35 31 4 3206
Figure 4. Cellular features of major lesions in DNA-Citoliq
samples: invasive squamous cell carcinoma with small and
medium-sized cells, some of them almost devoid of cyto-
plasm, with spindle, oval or round nuclei with severely
distorted chromatin. Haemorrhagic background is condensed
in clumps.
Figure 3. Cellular features of major lesions in DNA-Citoliq
samples: dyskaryotic cells depicting large nuclei, with coarse
chromatin, irregularly distributed.
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(3008), a one-category discrepancy in 3.5% (112),
and a discrepancy of two or more diagnostic categories
in 2.7% (86) of the pairs. Among the 288 women
considered abnormal (borderline or greater) by either
method, DNA-Citoliq was abnormal in 243 (84.4%)
when compared with 178 (61.8%) for the conven-
tional smears (McNemar test, P < 0.000). There were
many diagnostic discrepancies between DNA-Citoliq
and the conventional smear. For example, of 106
specimens identified as mild dyskaryosis by DNA-
Citoliq, 38 were called negative on the conventional
smear. Conversely, of 90 specimens diagnosed as mild
dyskaryosis on the conventional smear, 14 were
classified as negative by DNA-Citoliq. Remarkably, of
66 moderate/severe dyskaryosis lesions diagnosed by
DNA-Citoliq 28 (42%) were classified as negative by
conventional smear. By contrast, of 32 cases diag-
nosed as moderate/severe dyskaryosis by the conven-
tional smear, DNA-Citoliq classified three as
borderline and five as mild dyskaryosis but none were
called negative (Table 1).
Considering all specimens categorized as border-
line+, DNA-Citoliq detected 243, whereas conven-
tional smears identified 178 of these specimens
(McNemar test, P < 0.0001), giving an increase in
detection of abnormalities of 36.5% for DNA-Citoliq
versus the conventional smear. The borderline/dys-
karyosis ratio was 0.43 (53 : 122) with the conven-
tional smears and 0.39 (67 : 172) with DNA-Citoliq.
As shown in Table 2, when the cut-off for the
comparison was mild dyskaryosis+, DNA-Citoliq
detected 176 cases whereas 125 such cases were
detected in conventional smears (McNemar test,
P < 0.000), thus representing an incremental detec-
tion of 40.8%. Regarding moderate dyskaryosis or
greater (severe dyskaryosis and invasion), DNA-
Citoliq detected 70 cases, whereas only 35 cases were
identified by conventional smears (P < 0.000), corre-
sponding to a 100% increased detection, as shown in
Table 3. High-grade lesions (moderate and severe
dyskaryosis) were detected in 66 cases by DNA-
Citoliq, whereas only 32 cases were identified by
conventional smears (McNemar test, P < 0.000).
Among four cases diagnosed as invasive squamous
cell carcinoma by DNA-Citoliq, three were also
detected as such by conventional smear, and one case
was diagnosed as severe dyskaryosis.
Glandular epithelial lesions
Endocervical cells were, in most cases, well represen-
ted in DNA-Citoliq samples, either as single cells or as
groups of well-preserved cells (Table 4). However, this
population included only one case with in situ
adenocarcinoma and one case with invasive adeno-
carcinoma, both detected by both methods. Glandular
Table 2. Diagnostic performance of DNA-Citoliq system and
conventional smears for detecting squamous abnormalities.




Positive 100 25 125
Negative 76 3005 3081
Total 176 3030 3206
DNA-Citoliq mild dyskaryosis+ 176 5.5%
Conventional mild dyskaryosis+ 125 3.9%
Increment 51 40.8%
P < 0.00001.
Table 3. Diagnostic performance of DNA-Citoliq system and
conventional smears for detecting squamous abnormalities.




Positive 27 8 35
Negative 43 3128 3171









Table 4. Diagnostic performance of DNA-Citoliq system and






Negative 3174 7 0 0 3181
Borderline 22 1 0 0 23
AIS 0 0 1 0 1
Adenocarcinoma 0 0 0 1 1
Total 3196 8 1 1 3206
AIS, atypia in situ.
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borderline lesion was reported in 23 conventional
smears and in eight DNA-Citoliq samples (P ¼ 0.13).
Discussion
This study is the first assessment of the diagnostic
performance of the new DNA-Citoliq system, based on
a split-sample comparison. The final diagnosis (gold
standard) in the present study was not based on
histology but on a strict algorithm, with all discordant
cases submitted to a panel of cytopathologists for the
consensus diagnosis. Thus, the increased number of
cases detected by DNA-Citoliq system must be regar-
ded as presumptive disease rather than definite
lesions. DNA-Citoliq preparations detected 36.5%
more borderline+ than conventional smears. Simi-
larly, mild dyskaryosis+ was also more often detected
(40.8%), as well as moderate/severe dyskaryosis+
(100%).
When assessing new diagnostic systems for cervico-
vaginal screening it is recommended that a well-
established method be concomitantly used to avoid
any diagnostic inaccuracy that could potentially harm
the patient.13–17 Accordingly, the protocol was
designed prioritizing the conventional smear, i.e. an
additional sample for the new method would be taken
immediately after collecting material for the routine
smear. Bishop13 observed an increased level of detec-
tion of SIL with the Auto-Cyte LBC (86.7%) versus
the conventional smear (63.6%). These findings were
subsequently confirmed in several other reports14–17
and in a multicentre study,18 where the Auto-Cyte
system detected 31% more dyskaryosis in relation to
the conventional smears. Experience with ThinPrep,
another liquid-based system, also demonstrated
87.8% detection of mild dyskaryosis versus 68.1%
with conventional smears.14
Two studies have assessed both the sensitivity and
specificity of ThinPrep.19,20 The first study19 compared
ThinPrep versus conventional smear to diagnose mild
or more severe dyskaryosis using histology as the
reference standard. Sensitivity of 0.94 and specificity
of 0.58 was reported for ThinPrep, whereas conven-
tional smears had a sensitivity of 0.85 and a specificity of
0.36. Another study20 also compared ThinPrep and
conventional smears in a split-sample study. Positive
cases on either test were verified either cytologically or
histologically; histological verification was obtained on
a majority of severe dyskaryosis samples. The relative
true positive rate was 1.13, indicating that ThinPrep
had higher sensitivity, and the relative false-positive
rate was 1.12, translating as a slightly lower specificity
of ThinPrep.
A more accurate evaluation of the performance of
DNA-Citoliq would be to randomize women to be
examined either by DNA-Citoliq or by conventional
smear. Through this approach, known as direct-to-
vial, each method has an equal opportunity to work
with representative cervico-vaginal samples.1 The
detection of both low- and high-grade lesions seems
to be substantially improved by LBC.5,20–23 Indeed, a
direct-to-vial comparison study21 reported 1.58%
detection rate of mild dyskaryosis with conventional
smears and 2.52% in Auto-Cyte. In the same study,
moderate/severe dyskaryosis was detected in 0.38%
with conventional smears and in 0.68% of Auto-Cyte.
Another direct-to-vial study23 with Auto-Cyte in rela-
tion to conventional smear has confirmed the increased
detection of mild dyskaryosis (57%) and moderate/
severe dyskaryosis (55%). Thus, based on the experi-
ence with other LBC methods,5,20–23 one could antici-
pate that further improvement of lesion detection and
sample adequacy would be even higher in a direct-to-
vial study. An important aspect in studies dealing with
comparisons of test performance of cervico-vaginal
cytology is the nature of the gold standard for the
diagnosis. Due to logistical constraints, systematic
biopsy of all abnormal cytological results was not
possible in our study. Histological correlation clearly
demonstrated that dyskaryotic lesions detected with
LBC in excess of conventional smears were usually not
false positives.24 Therefore, follow-up histology-based
DNA-Citoliq studies are warranted.
Screeners received a 3-day training in preparation
for the study. Not surprisingly, the DNA-Citoliq rate
(1.8%) of unsatisfactory samples was quite similar to
other LBC.25 We would have expected the proportion
of inadequate samples to be lower had the specimen
for DNA-Citoliq slide not been taken after collecting
material for the conventional smear. A rather remark-
able adequacy rate found with the conventional
method could possibly be attributed to examiners
awareness of their participation in a multicentre
investigation.
Cytomorphology of epithelial cells was well defined,
leading to a prompt recognition of abnormal cells.
Moderate/severe dyskaryotic cells smaller than usu-
ally detected in conventional smears were sometimes
observed. This feature, also reported in the ThinPrep
samples, could be ascribed to the fixative solution. As
previously reported, UCM used in the DNA-Citoliq
System uses an N-butanol-based liquid. Columnar
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epithelial cells, both individually or in sheets, were
well represented and morphologically well preserved.
The low incidence of glandular cell abnormalities in
the present population prevented the appropriate
evaluation of DNA-Citoliq performance in such
lesions. As residual endocervical material was used
to prepare DNA-Citoliq slides, this could explain the
lower frequency of glandular borderline lesions when
compared with conventional smears.
A major reason for the advances achieved through
LBC techniques is the fixative liquid, which, in the
DNA-Citoliq system is UCM. The properties of UCM
have been presented previously.6,7 Besides yielding
a crisp cytomorphological presentation and showing
a retention of morphological details for at least
15 days after collection of the specimens, even at
high temperatures in several cities in Brazil where
the participating laboratories are located, UCM has
been shown to be efficient in preserving nucleic
acids, enabling the detection of HPV DNA either by
Hybrid Capture6 or by PCR.26 Our preliminary,
unpublished data also point to an excellent preser-
vation of cellular antigens in immunocytochemical
assays, as recently reported by Freitas et al.27 in
cell blocks from samples fixed with Thin-Prep
fixative.
Concerns about the costs of LBC have been
expressed in recent literature. Although Sulik et al.28
considered that new evidence should be provided
regarding its cost–benefit ratio, several authors
present impressive data on the potential global
reduction of costs of programmes employing LBC
for detection of pre-neoplastic cervical lesions.
Advantages of LBC include higher sensitivity, the
possibility for repeating the cytological preparations
if needed and the ready availability of material for
human papillomavirus testing without requiring
another clinic visit by the patient. The preparation
of each lot of 12 slides of DNA-Citoliq system
requires 7–9 minutes of hands-on technical time.
However, the screening time is reduced, in line with
a recent report by Hoerl et al.29
In conclusion, the manual, liquid-based DNA-
Citoliq system enabled the detection of a signifi-
cantly higher number of squamous lesions. Most
notably, DNA-Citoliq detected twice as many high-
grade lesions as the conventional smear in our
population of women. Future studies should assess
cases with histological confirmation, whereas glan-
dular lesions should be studied in populations with
high risk for adenocarcinoma.
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